The Role of Heat Shock Proteins in Type 1 Diabetes.

antigen specific immunotherapy autoantigens heat shock proteins metabolic stress type 1 diabetes type 1 diabetes pathogenesis

Journal

Frontiers in immunology
ISSN: 1664-3224
Titre abrégé: Front Immunol
Pays: Switzerland
ID NLM: 101560960

Informations de publication

Date de publication:
2020
Historique:
received: 30 09 2020
accepted: 30 11 2020
entrez: 15 2 2021
pubmed: 16 2 2021
medline: 24 6 2021
Statut: epublish

Résumé

Type 1 diabetes (T1D) is a T-cell mediated autoimmune disease characterized by recognition of pancreatic β-cell proteins as self-antigens, called autoantigens (AAgs), followed by loss of pancreatic β-cells. (Pre-)proinsulin ([P]PI), glutamic acid decarboxylase (GAD), tyrosine phosphatase IA-2, and the zinc transporter ZnT8 are key molecules in T1D pathogenesis and are recognized by autoantibodies detected in routine clinical laboratory assays. However, generation of new autoantigens (neoantigens) from β-cells has also been reported, against which the autoreactive T cells show activity. Heat shock proteins (HSPs) were originally described as "cellular stress responders" for their role as chaperones that regulate the conformation and function of a large number of cellular proteins to protect the body from stress. HSPs participate in key cellular functions under both physiological and stressful conditions, including suppression of protein aggregation, assisting folding and stability of nascent and damaged proteins, translocation of proteins into cellular compartments and targeting irreversibly damaged proteins for degradation. Low HSP expression impacts many pathological conditions associated with diabetes and could play a role in diabetic complications. HSPs have beneficial effects in preventing insulin resistance and hyperglycemia in type 2 diabetes (T2D). HSPs are, however, additionally involved in antigen presentation, presenting immunogenic peptides to class I and class II major histocompatibility molecules; thus, an opportunity exists for HSPs to be employed as modulators of immunologic responses in T1D and other autoimmune disorders. In this review, we discuss the multifaceted roles of HSPs in the pathogenesis of T1D and in autoantigen-specific immune protection against T1D development.

Identifiants

pubmed: 33584694
doi: 10.3389/fimmu.2020.612584
pmc: PMC7873876
doi:

Substances chimiques

Autoantigens 0
Heat-Shock Proteins 0

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

612584

Informations de copyright

Copyright © 2021 Moin, Nandakumar, Diane, Dehbi and Butler.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Références

Biochem Biophys Res Commun. 2002 Jun 14;294(3):592-6
pubmed: 12056808
J Autoimmun. 1996 Apr;9(2):159-66
pubmed: 8738959
Nat Rev Cardiol. 2014 Sep;11(9):516-29
pubmed: 25027488
Immunol Today. 1993 May;14(5):203-8
pubmed: 7686009
Clin Exp Immunol. 1993 Jun;92(3):391-6
pubmed: 8513574
Autoimmun Rev. 2009 Jul;8(8):687-91
pubmed: 19217947
Pharmacol Res. 2005 Feb;51(2):117-23
pubmed: 15629256
Int Immunopharmacol. 2016 Jun;35:235-242
pubmed: 27082999
J Neurol Sci. 2003 Oct 15;214(1-2):27-36
pubmed: 12972385
BMC Biochem. 2010 Nov 08;11:44
pubmed: 21059249
Lancet. 2014 Jan 4;383(9911):69-82
pubmed: 23890997
J Immunol. 1999 Mar 15;162(6):3256-62
pubmed: 10092777
J Biol Chem. 2005 Jun 17;280(24):23349-55
pubmed: 15826944
J Immunol. 1999 Aug 1;163(3):1398-408
pubmed: 10415040
Biochim Biophys Acta. 2013 Feb;1833(2):410-6
pubmed: 22445420
Immunogenetics. 1989;30(1):46-9
pubmed: 2568336
Scand J Immunol. 1993 Nov;38(5):491-5
pubmed: 7901896
Proc Natl Acad Sci U S A. 2015 Oct 6;112(40):E5496-502
pubmed: 26324934
Diabetes Metab Res Rev. 2007 May;23(4):269-75
pubmed: 17024692
J Diabetes Res. 2016;2016:8017571
pubmed: 27478851
PLoS One. 2019 Jan 10;14(1):e0208456
pubmed: 30629603
PLoS Genet. 2011 Sep;7(9):e1002293
pubmed: 21980299
Diabetes. 2008 Jul;57(7):1966-70
pubmed: 18390793
Can J Diabetes. 2019 Jul;43(5):345-353
pubmed: 30853267
Nat Clin Pract Endocrinol Metab. 2008 Jun;4(6):334-43
pubmed: 18446141
Ann N Y Acad Sci. 2013 Apr;1281:16-35
pubmed: 23323860
Cell Stress Chaperones. 2013 Nov;18(6):815-9
pubmed: 23681922
Curr Opin Immunol. 1989-1990 Feb;2(3):353-9
pubmed: 2534501
Antioxid Redox Signal. 2007 Apr;9(4):497-506
pubmed: 17280490
J Cell Sci. 2005 Aug 15;118(Pt 16):3631-8
pubmed: 16046478
Diabetes Metab Res Rev. 2007 May;23(4):276-85
pubmed: 17103487
Cell Stress Chaperones. 2007 Autumn;12(3):237-44
pubmed: 17915556
J Autoimmun. 1992 Aug;5(4):453-63
pubmed: 1418289
J Immunol. 2014 Dec 15;193(12):5765-71
pubmed: 25480955
J Autoimmun. 1999 Mar;12(2):121-9
pubmed: 10047432
Diabetes. 1997 May;46(5):758-64
pubmed: 9133541
Redox Biol. 2016 Aug;8:205-15
pubmed: 26820564
Front Oncol. 2015 Jan 29;5:7
pubmed: 25688334
Int J Mol Sci. 2020 Jul 26;21(15):
pubmed: 32722570
Annu Rev Genomics Hum Genet. 2013;14:301-23
pubmed: 23875801
Mediators Inflamm. 2015;2015:249205
pubmed: 25814786
J Biol Chem. 2000 Jun 30;275(26):19521-8
pubmed: 10751413
J Exp Med. 2005 Nov 7;202(9):1191-7
pubmed: 16260488
Cell Stress Chaperones. 2011 May;16(3):235-49
pubmed: 20963644
J Autoimmun. 1995 Dec;8(6):859-74
pubmed: 8824711
Lancet. 1991 Jun 8;337(8754):1368-72
pubmed: 1674762
Diabetes. 2005 Apr;54(4):1074-81
pubmed: 15793246
Front Immunol. 2016 May 24;7:201
pubmed: 27252703
J Immunol. 2009 Jun 15;182(12):7451-8
pubmed: 19494268
J Autoimmun. 2003 May;20(3):237-45
pubmed: 12753809
IUBMB Life. 2017 Aug;69(8):623-630
pubmed: 28631886
J Autoimmun. 2015 May;59:61-6
pubmed: 25772283
Diabetes Res. 1990 Jan;13(1):1-11
pubmed: 2097090
Immunol Lett. 2002 Mar 1;80(3):155-62
pubmed: 11803047
Clin Immunol. 2013 Dec;149(3):307-16
pubmed: 24090708
PLoS One. 2012;7(3):e32746
pubmed: 22412919
Biochem Biophys Res Commun. 2008 May 2;369(2):421-5
pubmed: 18282468
Nat Rev Endocrinol. 2009 Apr;5(4):219-26
pubmed: 19352320
Diabetes. 2017 Feb;66(2):460-473
pubmed: 27872147
Vaccine. 2010 Apr 26;28(19):3312-7
pubmed: 20226247
Immunity. 2001 Mar;14(3):303-13
pubmed: 11290339
J Autoimmun. 1998 Feb;11(1):73-81
pubmed: 9480725
Diabet Med. 1994 Jan-Feb;11(1):66-70
pubmed: 8181256
Arthritis Rheum. 2008 Feb;58(2):547-55
pubmed: 18240224
Immunogenetics. 1990;32(4):286-9
pubmed: 1978715
EMBO J. 2015 Nov 12;34(22):2775-88
pubmed: 26459514
Diabetes Metab Res Rev. 2007 May;23(4):286-91
pubmed: 17124721
Cell Death Dis. 2019 Apr 5;10(4):309
pubmed: 30952835
Dokl Biol Sci. 2020 Jul;493(1):124-127
pubmed: 32894426
Vaccine. 2004 Aug 13;22(23-24):3187-94
pubmed: 15297073
Ren Fail. 2016;38(3):404-10
pubmed: 26820050
Lancet. 2018 Aug 11;392(10146):477-486
pubmed: 30129464
Diabetes. 2000 Jul;49(7):1123-30
pubmed: 10909968
Curr Diab Rep. 2009 Apr;9(2):105-12
pubmed: 19323954
Diabetes Obes Metab. 2009 Feb;11 Suppl 1:60-6
pubmed: 19143816
Proc Natl Acad Sci U S A. 1990 Feb;87(4):1576-80
pubmed: 2406723
Diabetes. 1997 Feb;46(2):232-6
pubmed: 9000699
Lancet. 2003 Dec 13;362(9400):1971-7
pubmed: 14683657
J Clin Invest. 2011 Nov;121(11):4348-61
pubmed: 22019588
J Pathol. 1991 Oct;165(2):97-103
pubmed: 1744803
Autoimmunity. 2002 Sep;35(6):389-95
pubmed: 12568119
J Immunol. 2002 Nov 15;169(10):6030-5
pubmed: 12421990
Diabetes. 2003 May;52(5):1128-36
pubmed: 12716742
Clin Exp Immunol. 2008 Jun;152(3):488-97
pubmed: 18422727
Pflugers Arch. 2010 Sep;460(4):703-18
pubmed: 20652307
Diabetologia. 2004 Jul;47(7):1331-1333
pubmed: 15248047
Int Immunol. 2006 Oct;18(10):1413-9
pubmed: 16893923
Am J Hum Genet. 2014 Dec 4;95(6):689-97
pubmed: 25466870
Diabetologia. 2012 Sep;55(9):2417-20
pubmed: 22699564
Biochem Biophys Res Commun. 2009 Aug 14;386(1):192-6
pubmed: 19520060
J Immunol. 2005 Jul 1;175(1):276-85
pubmed: 15972659
Diabetes. 2002 Feb;51(2):347-55
pubmed: 11812741
Endocrinology. 1990 Nov;127(5):2290-7
pubmed: 2171911
Proc Natl Acad Sci U S A. 1989 Mar;86(6):1968-72
pubmed: 2538825
Cardiovasc Hematol Agents Med Chem. 2012 Sep;10(3):223-33
pubmed: 22632266
Cell Stress Chaperones. 2010 Nov;15(6):761-70
pubmed: 20524162
Lancet. 1990 Sep 8;336(8715):583-5
pubmed: 1975377
Diabetes. 2003 Jan;52(1):93-101
pubmed: 12502498
Mol Cell Biol. 1989 May;9(5):2279-83
pubmed: 2568584
Chem Biol Interact. 2014 Nov 5;223:125-33
pubmed: 25301743
Clin Immunol Immunopathol. 1996 Jun;79(3):252-5
pubmed: 8635283
Vaccine. 2007 Mar 1;25(11):2043-50
pubmed: 17224213
Front Cell Dev Biol. 2015 Oct 27;3:67
pubmed: 26579520
Transl Res. 2016 Feb;168:96-106.e1
pubmed: 26397425
Lancet. 1994 Mar 19;343(8899):704-6
pubmed: 7907681
Trends Immunol. 2011 Feb;32(2):89-95
pubmed: 21145789
Sci Transl Med. 2013 Nov 13;5(211):211ra156
pubmed: 24225943
Diabetes Metab Res Rev. 2012 Sep;28(6):527-34
pubmed: 22492505
Immunity. 2002 Sep;17(3):353-62
pubmed: 12354387
Immunity. 2010 Apr 23;32(4):468-78
pubmed: 20412757
Cell Stress Chaperones. 2019 May;24(3):475-479
pubmed: 31073900
Adv Cancer Res. 1993;62:153-77
pubmed: 8109317
Diabetes. 1993 Jun;42(6):908-13
pubmed: 8098696
Diabetes. 2012 Apr;61(4):818-27
pubmed: 22442300
Front Immunol. 2012 Mar 30;3:63
pubmed: 22566944
J Clin Invest. 1995 Jun;95(6):2840-5
pubmed: 7769124
Annu Rev Physiol. 1999;61:243-82
pubmed: 10099689
Ann N Y Acad Sci. 2007 Oct;1113:217-37
pubmed: 17584980
Lancet. 2001 Nov 24;358(9295):1749-53
pubmed: 11734230

Auteurs

Abu Saleh Md Moin (ASM)

Diabetes Research Center (DRC), Qatar Biomedical Research Institute (QBRI), Hamad Bin Khalifa University (HBKU), Qatar Foundation (QF), Doha, Qatar.

Manjula Nandakumar (M)

Diabetes Research Center (DRC), Qatar Biomedical Research Institute (QBRI), Hamad Bin Khalifa University (HBKU), Qatar Foundation (QF), Doha, Qatar.

Abdoulaye Diane (A)

Diabetes Research Center (DRC), Qatar Biomedical Research Institute (QBRI), Hamad Bin Khalifa University (HBKU), Qatar Foundation (QF), Doha, Qatar.

Mohammed Dehbi (M)

Diabetes Research Center (DRC), Qatar Biomedical Research Institute (QBRI), Hamad Bin Khalifa University (HBKU), Qatar Foundation (QF), Doha, Qatar.

Alexandra E Butler (AE)

Diabetes Research Center (DRC), Qatar Biomedical Research Institute (QBRI), Hamad Bin Khalifa University (HBKU), Qatar Foundation (QF), Doha, Qatar.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH